Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 7, 2019 (8 years ago)

Mometasone Furoate Cream

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37

Affected NDC 0713-0726-37

Compare with the code on your package — it is the most precise check available.

Drug: Mometasone

Recalling firm
ACP Nimble Buyer, Inc.
NDC code
0713-0726-37
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0514-2019 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Mometasone recalls

See all
Class III · Low risk

SINUVA (mometasone furoate)

Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Terminated Dissolution failure Intersect ENT, Inc. NDC 10599-003-01 D-0167-2023

Other labeling / mix-up recalls from 2019

All labeling / mix-up recalls
Class II · Moderate risk

Theraflu Cough Relief

Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.

Terminated Labeling / mix-up GSK Consumer Health, Inc D-0996-2020
Class II · Moderate risk

Testosterone Topical Cream 4%

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0820-2020
Class II · Moderate risk

Tadalafil 6 mg Capsule

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0819-2020
Class II · Moderate risk

Tadalafil 20 mg Troche

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0818-2020